1.
Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation. Mediterr J Hematol Infect Dis [Internet]. 2026 Jan. 1 [cited 2026 Apr. 29];18(1):e2026009. Available from: https://www.mjhid.org/mjhid/article/view/6169